高危类风湿关节炎一级亲属中替代性自身抗体扩增不随抗环瓜氨酸蛋白抗体演变
该研究在 First Nations 队列的 50 例 RA 患者和 64 例高危一级亲属(FDR)中评估多种自身抗体,发现 78.9% 受试者 ANA 阳性(≥1:80),但 FDR 中针对非关节自身抗原的自身反应性未见增加,替代性自身免疫扩增仅限于已确诊 RA 患者。
要点
- 高危 FDR 中 ANA 阳性率虽高,但非关节炎自身抗体未见随 ACPA 扩增。
- 替代性自身免疫扩增主要见于已确诊 RA 患者,而非临床前阶段。
- AC-4 及混合 ANA 模式可在进展者发病时观察到。
核心结论
- 替代性自身免疫和 ANA 阳性在 First Nations 人群中广泛流行,包括无症状血清阴性 FDR。
- 在 FDR 中替代性自身免疫扩增不与 ACPA 扩增平行,且仅限于已确诊 RA 患者。
研究设计与样本
- 研究纳入 50 例 RA 患者和 64 例 RA 患者的一级亲属(FDR),采集静脉血并检测血清。
- 采用 ELISA 检测高敏 C 反应蛋白、ACPA 及自身抗体,速率散射比浊法检测 RF,Hep-2 间接免疫荧光法检测 ANA。
主要发现
- 78.9% 的研究队列 ANA 阳性(≥1:80),呈均质型、细斑点型(AC-1 和 AC-4)或混合 IFA 模式。
- AC-4 和混合 ANA 模式在进展者疾病发作时也可观察到。
- 所有 RA 患者关节炎相关自身抗体高流行,同时针对其他自身抗原的可提取核抗原阳性自身抗体也高流行。
- FDR 中无论横断面还是纵向收集的进展者 RA 发病前样本,均未观察到针对非关节炎自身抗原的血清自身反应性增加。
关键数值与推荐
- ANA 阳性定义为≥1:80,按国际共识命名分类为不同抗细胞(AC)模式。
临床怎么用
- 对于 RA 高危一级亲属,ANA 阳性常见但非关节炎自身抗体扩增不随 ACPA 演变,临床可关注 ACPA 而非替代性自身抗体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Co-occurrence of autoantibodies specific for ≥1 autoimmune disease is widely prevalent in rheumatoid arthritis (RA) patients. To understand the prevalence of polyautoimmunity in preclinical RA, we performed a comprehensive autoantibody assessment in a First Nations cohort of at-risk first-degree relatives (FDR) of RA patients, a subset of whom subsequently developed RA (progressors). METHODS: Venous blood was collected from all study participants (n = 50 RA patients and 64 FDR) at scheduled visits, and serum was stored at -20°C. High-sensitivity C-reactive protein level, anti-citrullinated protein antibody (ACPA) status, and autoantibody status were determined using commercially available enzyme-linked immunosorbent assay kits. Rheumatoid factor (RF) was detected by nephelometry. Antinuclear autoantibodies (ANA) were identified using Hep-2 indirect immunofluorescence assay (IFA) and classified according to international consensus nomenclature as various anti-cell (AC) patterns. RESULTS: Of our study cohort, 78.9% had positive ANA reactivity (≥1:80), which was either a homogenous, fine-speckled (AC-1 and AC-4) or mixed IFA pattern. Importantly, the AC-4 and mixed ANA patterns were also observed in progressors at the time of disease onset. While all of the RA patients showed a high prevalence of arthritis-associated autoantibodies, they also had a high prevalence of extractable nuclear antigen-positive autoantibodies to other autoantigens. In FDR, we did not observe any increase in serum autoreactivity to nonarthritis autoantigens, either cross-sectionally or in samples collected longitudinally from progressors prior to RA onset. CONCLUSION: While alternative autoimmunity and ANA positivity are widely prevalent in First Nations populations, including asymptomatic, seronegative FDR, expansion of alternative autoimmunity does not occur in parallel with ACPA expansion in FDR and is restricted to patients with established RA.
引用
- Anaparti V, Smolik I, Meng X, et al. Expansion of Alternative Autoantibodies Does Not Follow the Evolution of Anti-Citrullinated Protein Antibodies in Preclinical Rheumatoid Arthritis: An Analysis in At-Risk First Degree Relatives. Arthritis Rheumatol. 2021. PMID: 33538122. doi:10.1002/art.41675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。